<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Cold Spring Harb Mol Case Stud</journal-id>
<journal-id journal-id-type="iso-abbrev">Cold Spring Harb Mol Case Stud</journal-id>
<journal-id journal-id-type="publisher-id">cshmcs</journal-id>
<journal-id journal-id-type="hwp">cshmcs</journal-id>
<journal-title-group>
<journal-title>Cold Spring Harbor Molecular Case Studies</journal-title>
</journal-title-group>
<issn pub-type="ppub">2373-2865</issn>
<issn pub-type="epub">2373-2873</issn>
<publisher>
<publisher-name>Cold Spring Harbor Laboratory Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27148570</article-id>
<article-id pub-id-type="pmc">4850885</article-id>
<article-id pub-id-type="doi">10.1101/mcs.a000455</article-id>
<article-id pub-id-type="publisher-id">YeMCS000455</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Report</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>De novo <italic>POGZ</italic> mutations are associated with neurodevelopmental disorders and microcephaly</article-title>
<alt-title alt-title-type="left-running">POGZ mutations cause neurodevelopmental delay and microcephaly</alt-title>
<alt-title alt-title-type="right-running">POGZ mutations cause neurodevelopmental delay and microcephaly</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Ye</surname>
<given-names>Yizhou</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cho</surname>
<given-names>Megan T.</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Retterer</surname>
<given-names>Kyle</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Alexander</surname>
<given-names>Nora</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ben-Omran</surname>
<given-names>Tawfeg</given-names>
</name>
<xref ref-type="aff" rid="af2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Al-Mureikhi</surname>
<given-names>Mariam</given-names>
</name>
<xref ref-type="aff" rid="af2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cristian</surname>
<given-names>Ingrid</given-names>
</name>
<xref ref-type="aff" rid="af3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wheeler</surname>
<given-names>Patricia G.</given-names>
</name>
<xref ref-type="aff" rid="af3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Crain</surname>
<given-names>Carrie</given-names>
</name>
<xref ref-type="aff" rid="af3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zand</surname>
<given-names>Dina</given-names>
</name>
<xref ref-type="aff" rid="af4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Weinstein</surname>
<given-names>Veronique</given-names>
</name>
<xref ref-type="aff" rid="af4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vernon</surname>
<given-names>Hilary J.</given-names>
</name>
<xref ref-type="aff" rid="af5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>McClellan</surname>
<given-names>Rebecca</given-names>
</name>
<xref ref-type="aff" rid="af5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Krishnamurthy</surname>
<given-names>Vidya</given-names>
</name>
<xref ref-type="aff" rid="af6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vitazka</surname>
<given-names>Patrik</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Millan</surname>
<given-names>Francisca</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chung</surname>
<given-names>Wendy K.</given-names>
</name>
<xref ref-type="aff" rid="af7">7</xref>
</contrib>
</contrib-group>
<aff id="af1"><label>1</label>GeneDx, Gaithersburg, Maryland 20877, USA;</aff>
<aff id="af2"><label>2</label>Clinical and Metabolic Genetics, Hamad Medical Corporation, Doha, Qatar;</aff>
<aff id="af3"><label>3</label>Nemours Children's Hospital, Orlando, Florida 32827, USA;</aff>
<aff id="af4"><label>4</label>Children's National Medical Center, Washington, D.C. 20010, USA;</aff>
<aff id="af5"><label>5</label>Kennedy Krieger Institute, Baltimore, Maryland 21205, USA;</aff>
<aff id="af6"><label>6</label>Pediatrics and Genetics, Alpharetta, Georgia 30005, USA;</aff>
<aff id="af7"><label>7</label>Departments of Pediatrics and Medicine, Columbia University Medical Center, New York, New York 10032, USA</aff>
<author-notes>
<corresp>Corresponding author: <email>wkc15@columbia.edu</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>10</month>
<year>2015</year>
</pub-date>
<volume>1</volume>
<issue>1</issue>
<elocation-id>a000455</elocation-id>
<history>
<date date-type="received">
<day>3</day>
<month>6</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>28</day>
<month>7</month>
<year>2015</year>
</date>
</history>
<permissions>
<copyright-statement>
<ext-link ext-link-type="uri" xlink:href="http://www.molecularcasestudies.cshlp.org/site/misc/terms.xhtml">© 2015 Ye et al.; Published by Cold Spring Harbor Laboratory Press</ext-link>
</copyright-statement>
<copyright-year>2015</copyright-year>
<license xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">
<license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">Creative Commons Attribution-NonCommercial License</ext-link>, which permits reuse and redistribution, except for commercial purposes, provided that the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="YeMCS000455.pdf"></self-uri>
<abstract>
<p>Seven patients with similar phenotypes of developmental delay and microcephaly were found by whole-exome sequencing to have de novo loss-of-function mutations in <italic>POGZ</italic>. POGZ is a pogo transposable element-derived protein with a zinc finger cluster. The protein is involved in normal kinetochore assembly and mitotic sister chromatid cohesion and mitotic chromosome segregation. POGZ deficiency may affect mitosis, disrupting brain development and function.</p>
</abstract>
<kwd-group>
<kwd>intellectual disability, severe</kwd>
<kwd>microcephaly</kwd>
<kwd>severe global developmental delay</kwd>
</kwd-group>
<counts>
<page-count count="8"></page-count>
</counts>
</article-meta>
</front>
<body><sec id="s1" sec-type="introduction"><title>INTRODUCTION</title><p>De novo mutations are increasingly recognized to play an important role in sporadic, severe neurodevelopmental disorders because of the deleterious effect on reproductive fitness (<xref ref-type="bibr" rid="YEMCS000455C21">Veltman and Brunner 2012</xref>). For genetically heterogeneous disorders such as developmental delay and intellectual disability (ID), whole-exome sequencing (WES) can identify a genetic etiology in up to 30% of cases when chromosomal array and fragile X testing are normal (<xref ref-type="bibr" rid="YEMCS000455C23">Yang et al. 2013</xref>, <xref ref-type="bibr" rid="YEMCS000455C24">2014</xref>). When analyzed together with parental samples, WES readily identifies de novo variants. Here we describe seven patients with a similar phenotype of developmental delay and microcephaly, six of whom have de novo predicted loss-of-function mutations in pogo transposable element with ZNF domain (<italic>POGZ)</italic>. <italic>POGZ</italic> is located on Chromosome 1q21.3 and is a transposable element with a zinc finger domain involved in kinetochore assembly and mitotic sister chromatid cohesion and mitotic chromosome segregation (<xref ref-type="bibr" rid="YEMCS000455C17">Nozawa et al. 2010</xref>).</p></sec><sec id="s2" sec-type="results"><title>RESULTS</title><p>For 2415 patients referred for clinical WES for neurodevelopmental disorders, exome sequencing produced an average of ∼9.0 Gb of sequence per sample. Mean coverage of captured regions was ∼96× per sample with &gt;96% covered with at least 10× coverage, an average of 94% of base call quality of Q30 or greater, and an overall average mean quality score of &gt;Q36 (Supplemental Table S1). Filtering of common SNPs (&gt;10% frequency present in 1000 Genomes database) resulted in approximately 5500 variants per proband sample. Seven unrelated patients were found to have heterozygous changes in <italic>POGZ</italic> that are predicted to be deleterious, 0.29% of the cases referred for neurodevelopmental disorders. In these families, 230 genes (289 unique sequence changes) of interest were identified across five families when considering all possible modes of inheritance (<xref ref-type="table" rid="YEMCS000455TB1">Table 1</xref>). Because parental samples were not available for Patient 5, inheritance of variants could not be determined, so those data are not included in <xref ref-type="table" rid="YEMCS000455TB1">Table 1</xref>. Data from Patient 6 were not included in <xref ref-type="table" rid="YEMCS000455TB1">Table 1</xref> because the heterozygous loss of function of POGZ was the result of a copy-number variant (<xref ref-type="bibr" rid="YEMCS000455C19">Retterer et al. 2014</xref>). Evaluation of the 230 genes eliminated 229 genes that did not segregate with the phenotype in the family, leaving one gene for which there was clinical overlap of the patients’ phenotype.</p><table-wrap id="YEMCS000455TB1" orientation="portrait" position="float"><label>Table 1.</label><caption><p>Variants identified from whole-exome sequencing of five families</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/></colgroup><thead><tr><th colspan="1" rowspan="1"></th><th align="center" colspan="1" rowspan="1">Filtering results</th><th align="center" colspan="1" rowspan="1">Manual review</th><th align="center" colspan="1" rowspan="1">Resulting genes of interest</th></tr></thead><tbody><tr><td colspan="1" rowspan="1">Homozygous (# seq changes)</td><td colspan="1" rowspan="1">74 (77)</td><td colspan="1" rowspan="1">0 (0)</td><td colspan="1" rowspan="1">0 (0)</td></tr><tr><td colspan="1" rowspan="1">Compound Heterozygous (# seq changes)</td><td colspan="1" rowspan="1">31 (85)</td><td colspan="1" rowspan="1">1 (2)</td><td colspan="1" rowspan="1">0 (0)</td></tr><tr><td colspan="1" rowspan="1">De novo (# seq changes)</td><td colspan="1" rowspan="1">93 (95)</td><td colspan="1" rowspan="1">3 (3)</td><td colspan="1" rowspan="1">1 (1)</td></tr><tr><td colspan="1" rowspan="1">X-linked genes (# seq changes)</td><td colspan="1" rowspan="1">32 (32)</td><td colspan="1" rowspan="1">0 (0)</td><td colspan="1" rowspan="1">0 (0)</td></tr><tr><td colspan="1" rowspan="1">Total genes (# seq changes)</td><td colspan="1" rowspan="1">230 (289)</td><td colspan="1" rowspan="1">4 (5)</td><td colspan="1" rowspan="1">1 (1)</td></tr></tbody></table></table-wrap><p>The seven patients in this report all have novel variants predicted to cause loss of function including frameshift and nonsense mutations and one patient with a heterozygous deletion of exons 4–19 (<xref ref-type="fig" rid="YEMCS000455F1">Fig. 1</xref>). In six patients the <italic>POGZ</italic> variant was de novo while the inheritance could not be determined in the seventh patient because parental samples were not available for testing. None of these variants are observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, in ExAC, or in our own local database of 8800 exomes from unrelated unaffected adults, indicating that these variants are not common. In the six patients for whom parents were available, these variants are de novo. In addition, Individual 3 was found to be hemizygous for an inherited variant in the <italic>ZNF81</italic> gene, located on the X chromosome. Although this gene may be associated with ID based on one missense variant reported previously, variants in this gene have also been frequently seen in the NHLBI Exome Sequencing Project; therefore, it is more likely that the <italic>POGZ</italic> variant explains the ID in this individual, although the <italic>ZNF81</italic> variant cannot be completely ruled out. Individual 6 has a deletion involving exons 4 through 19 of <italic>POGZ</italic>, and it also encompasses part of the <italic>PSMB4</italic> gene that has not previously been associated with any phenotypic consequences.</p><fig id="YEMCS000455F1" orientation="portrait" position="float"><label>Figure 1.</label><caption><p>Location of pathogenic variants in <italic>POGZ</italic>.</p></caption><graphic xlink:href="YeMCS000455_F1"></graphic></fig><p>The phenotype of the seven unrelated patients with predicted loss of function rare variants in <italic>POGZ</italic> that are predicted to be deleterious are similar (<xref ref-type="table" rid="YEMCS000455TB2">Table 2</xref>). The patients range in age from 1 to 16 yr old. All seven patients are developmentally delayed including significantly delayed walking and talking. Six patients whose cognitive status was known have intellectual disabilities based on clinician report from standardized measures such as developmental or intelligence quotients. Head circumferences ranged from &lt;3 percentile to 25 percentile, and three patients are microcephalic, with an additional four patients with head circumferences at the 3 percentile to 25 percentile. Six patients whose muscle tone is known are hypotonic. Six patients have dysmorphic facial features, including hypertelorism and bushy eyebrows as well as some patients who were noted to have a tented upper lip, short philtrum, and abnormal nose (underdeveloped alae, short nose, broad nasal bridge) (<xref ref-type="fig" rid="YEMCS000455F2">Fig. 2</xref>). A distinguishing physical feature is the hands with broad and/or adducted thumbs and syndactyly, which is present in five patients. Three out of five patients who had brain MRIs were found to have abnormalities. One patient has polymicrogyria, one has a small optic chiasm, dysplasia of cerebellum, and periventricular white matter injury, and another has cortical atrophy and atrophy of the corpus callosum. Three patients have cyclic vomiting. Less commonly reported clinical features include behavioral abnormalities (autism, anxiety, and attention deficit hyperactivity disorders), contractures, failure to thrive, and migraines.</p><fig id="YEMCS000455F2" orientation="portrait" position="float"><label>Figure 2.</label><caption><p>Facial characteristics of two individuals with a de novo <italic>POGZ</italic> variant. Individual 1: large ears, hypertelorism, oral hypotonia, full lower lip. Individual 3: hypertelorism, depressed and broad nasal bridge, and tented upper lip.</p></caption><graphic xlink:href="YeMCS000455_F2"></graphic></fig><table-wrap id="YEMCS000455TB2" orientation="portrait" position="float"><label>Table 2.</label><caption><p>Clinical phenotype and genotypes of POGZ mutation carriers</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="left" span="1"/><col align="left" span="1"/></colgroup><thead><tr><th align="left" colspan="1" rowspan="1">Individual</th><th align="center" colspan="1" rowspan="1">Age</th><th align="center" colspan="1" rowspan="1">Gender</th><th align="center" colspan="1" rowspan="1">Variant</th><th align="center" colspan="1" rowspan="1">De novo/inherited</th><th align="center" colspan="1" rowspan="1">Develop
mental delay</th><th align="center" colspan="1" rowspan="1">Intellectual disability</th><th align="center" colspan="1" rowspan="1">Age at walking</th><th align="center" colspan="1" rowspan="1">Age at talking</th><th align="center" colspan="1" rowspan="1">Hypotonia</th><th align="center" colspan="1" rowspan="1">Migraines</th><th align="center" colspan="1" rowspan="1">OFC</th><th align="center" colspan="1" rowspan="1">Brain abnormality</th><th align="center" colspan="1" rowspan="1">Cyclic vomiting</th><th align="center" colspan="1" rowspan="1">Dysmorphic</th><th align="center" colspan="1" rowspan="1">Additional clinical features</th><th align="center" colspan="1" rowspan="1">Additional genetic contributions</th></tr></thead><tbody><tr><td colspan="1" rowspan="2">1</td><td colspan="1" rowspan="2">8 yr</td><td colspan="1" rowspan="2">M</td><td colspan="1" rowspan="1">c.2094_2097dupAACT</td><td colspan="1" rowspan="2">De novo</td><td colspan="1" rowspan="2">Yes</td><td colspan="1" rowspan="2">Yes</td><td colspan="1" rowspan="2">Never</td><td colspan="1" rowspan="2">Never</td><td colspan="1" rowspan="2">Yes</td><td colspan="1" rowspan="2">No</td><td colspan="1" rowspan="2">&lt;3%ile</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="2">No</td><td colspan="1" rowspan="2">Yes</td><td colspan="1" rowspan="2">Syndactyly, scoliosis, contractures</td><td colspan="1" rowspan="2"></td></tr><tr><td colspan="1" rowspan="1">p.V700NfsX7</td><td colspan="1" rowspan="1">polymicrogyria</td></tr><tr><td colspan="1" rowspan="2">2</td><td colspan="1" rowspan="2">10 yr</td><td colspan="1" rowspan="2">F</td><td colspan="1" rowspan="1">c.C3031T</td><td colspan="1" rowspan="2">De novo</td><td colspan="1" rowspan="2">Yes</td><td colspan="1" rowspan="2">Yes (borderline)</td><td colspan="1" rowspan="2">2 yr</td><td colspan="1" rowspan="2">3 yr</td><td colspan="1" rowspan="2">Yes</td><td colspan="1" rowspan="2">Yes</td><td colspan="1" rowspan="2">3%ile–10%ile (acquired)</td><td colspan="1" rowspan="2">No</td><td colspan="1" rowspan="2">Yes</td><td colspan="1" rowspan="2">Yes</td><td colspan="1" rowspan="2">Autism, anxiety, repetitive behaviors</td><td colspan="1" rowspan="2"></td></tr><tr><td colspan="1" rowspan="1">p.Q1011X</td></tr><tr><td colspan="1" rowspan="2">3</td><td colspan="1" rowspan="2">5 yr</td><td colspan="1" rowspan="2">M</td><td colspan="1" rowspan="2">c.2750dupC<break></break>p.P918TfsX26</td><td colspan="1" rowspan="2">De novo</td><td colspan="1" rowspan="2">Yes</td><td colspan="1" rowspan="2">Yes</td><td colspan="1" rowspan="2">5 yr</td><td colspan="1" rowspan="2">5 yr</td><td colspan="1" rowspan="2">Yes</td><td colspan="1" rowspan="2">UKN</td><td colspan="1" rowspan="2">&lt;3%ile (congenital)</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="2">Yes</td><td colspan="1" rowspan="2">Yes</td><td colspan="1" rowspan="2">Failure to thrive</td><td colspan="1" rowspan="2">Hemizygous <italic>ZNF81</italic></td></tr><tr><td colspan="1" rowspan="1">Small optic chiasm, dysplasia of cerebellum (L≫R), periventricular white matter injury</td></tr><tr><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">16 yr</td><td colspan="1" rowspan="1">M</td><td colspan="1" rowspan="1">c.3041delA<break></break>p.Q1014RfsX5</td><td colspan="1" rowspan="1">De novo</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">UKN</td><td colspan="1" rowspan="1">UKN</td><td colspan="1" rowspan="1">UKN</td><td colspan="1" rowspan="1">UKN</td><td colspan="1" rowspan="1">25%ile</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">UKN</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">Obesity, mild finger syndactyly</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">5</td><td colspan="1" rowspan="1">10 yr</td><td colspan="1" rowspan="1">M</td><td colspan="1" rowspan="1">c.2195_2196delCT<break></break>p.P732RfsX11</td><td colspan="1" rowspan="1">UKN</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">UKN</td><td colspan="1" rowspan="1">UKN</td><td colspan="1" rowspan="1">UKN</td><td colspan="1" rowspan="1">UKN</td><td colspan="1" rowspan="1">25%ile</td><td colspan="1" rowspan="1">UKN</td><td colspan="1" rowspan="1">UKN</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">Broad thumbs, hands</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">6</td><td colspan="1" rowspan="1">9 yr</td><td colspan="1" rowspan="1">F</td><td colspan="1" rowspan="1">32 kb deletion in 1q21.3 (exons 4–19 of <italic>POGZ</italic>)</td><td colspan="1" rowspan="1">De novo</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">20 mo</td><td colspan="1" rowspan="1">14 mo</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">10%ile–25%ile</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">Broad toes, thumbs, spatulate fingers, ADHD</td><td colspan="1" rowspan="1">Deletion encompasses part of <italic>PSMB4</italic></td></tr><tr><td colspan="1" rowspan="2">7</td><td colspan="1" rowspan="2">1 yr</td><td colspan="1" rowspan="2">M</td><td colspan="1" rowspan="2">c.2514dupC<break></break>p.S839LfsX25</td><td colspan="1" rowspan="2">De novo</td><td colspan="1" rowspan="2">Yes</td><td colspan="1" rowspan="2">N/A</td><td colspan="1" rowspan="2">Never</td><td colspan="1" rowspan="2">Never</td><td colspan="1" rowspan="2">Yes</td><td colspan="1" rowspan="2">N/A</td><td colspan="1" rowspan="2">&lt;5%ile (congenital)</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="2">No</td><td colspan="1" rowspan="2">No</td><td colspan="1" rowspan="2">Adducted thumbs, BL hearing loss</td><td colspan="1" rowspan="2"></td></tr><tr><td colspan="1" rowspan="1">Cortical atrophy and atrophy of corpus callosum</td></tr><tr><td colspan="1" rowspan="1">Totals</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">De novo in 6/6</td><td colspan="1" rowspan="1">7/7</td><td colspan="1" rowspan="1">6/6</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">6/6</td><td colspan="1" rowspan="1">2/3</td><td colspan="1" rowspan="1">Microcephaly in 3/7</td><td colspan="1" rowspan="1">3/5</td><td colspan="1" rowspan="1">3/7</td><td colspan="1" rowspan="1">6/7</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td></tr></tbody></table><table-wrap-foot><fn><p>OFC, occipital frontal circumference; M, male; F, female; %ile, percentile; UKN, unknown; N/A, not applicable; BL, bilateral.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3" sec-type="discussion"><title>DISCUSSION</title><p>Patients from seven independent families with a similar phenotype of severe developmental delay and small head size were all found to have likely gene damaging mutations in <italic>POGZ</italic> that were de novo in all six cases evaluable.</p><p>POGZ is essential for normal kinetochore assembly, mitotic sister chromatid cohesion and mitotic chromosome segregation (<xref ref-type="bibr" rid="YEMCS000455C17">Nozawa et al. 2010</xref>). POGZ modulates mitotic progression at multiple steps, and most of its regulatory roles are tightly linked to the chromosomal passenger complex (CPC) (<xref ref-type="bibr" rid="YEMCS000455C17">Nozawa et al. 2010</xref>). CPC is composed of four different subunits, including Aurora B that regulates key events during mitosis (<xref ref-type="bibr" rid="YEMCS000455C3">Carmena et al. 2012</xref>). It is dynamically localized at different times during mitosis to ensure the effective and spatially restricted phosphorylation of substrates (<xref ref-type="bibr" rid="YEMCS000455C3">Carmena et al. 2012</xref>). During interphase, CPC targets heterochromatin protein 1 α (HP1α), which interacts with chromatin, maintains heterochromatin structure, and is localized to pericentromeric heterochromatin and chromosome arms (<xref ref-type="bibr" rid="YEMCS000455C22">Yamagishi et al. 2008</xref>; <xref ref-type="bibr" rid="YEMCS000455C18">Prasanth et al. 2010</xref>; <xref ref-type="bibr" rid="YEMCS000455C3">Carmena et al. 2012</xref>). When entering mitosis, HP1α and CPC are dissociated from the chromosome arms. POGZ, competing with PxVxL-domain proteins, binds to HP1α. When POGZ binds HP1α, the HP1α-chromatin interaction becomes unstable. Aurora B-dependent phosphorylation at Ser 10 of histone H3 promotes the dissociation of HP1α from the chromosome arms (<xref ref-type="bibr" rid="YEMCS000455C7">Fischle et al. 2005</xref>; <xref ref-type="bibr" rid="YEMCS000455C11">Hirota et al. 2005</xref>). Both Aurora B activation and POGZ binding contribute to the dissociation of HP1α from the chromatin, as well as the facilitation of CPC enrichment at inner centromeres. In late mitosis, CPC binds to microtubules at the spindle midzone and executes anaphase chromatid compaction (<xref ref-type="bibr" rid="YEMCS000455C3">Carmena et al. 2012</xref>).</p><p><italic>POGZ</italic>-knockdown cells exhibit disruption of HP1α dissociation from the chromosome arms, and as a consequence, disrupted CPC translocalization. POGZ depletion also reduced the phosphorylation activity of Aurora B kinase (<xref ref-type="bibr" rid="YEMCS000455C17">Nozawa et al. 2010</xref>). Similar to observations of POGZ depleted cells, Aurora B inhibition impairs CPC localization at centromeres during mitosis (<xref ref-type="bibr" rid="YEMCS000455C17">Nozawa et al. 2010</xref>).</p><p>As a result of POGZ deficiency, the majority of cells is unable to form metaphase plates, and will exit mitosis prematurely. One of the characteristic features of premature mitotic exit is the formation of polyploidy cells, which can lead to cell death or genome instability in subsequent division cycles. The POGZ deficiency phenotype is similar to that of loss-of-function mutation models of other CPC proteins: the mutant cells undergo multiple consecutive abnormal mitoses, producing polyploidy cells, which results in abnormal organ development (<xref ref-type="bibr" rid="YEMCS000455C10">Hanson et al. 2005</xref>; <xref ref-type="bibr" rid="YEMCS000455C20">Thornton and Woods 2009</xref>). Mutations in genes, such as <italic>ASPM</italic>, that lead to defects in the mitotic spindle, cause congenital microcephaly and intellectual disability (<xref ref-type="bibr" rid="YEMCS000455C1">Bond et al. 2002</xref>, <xref ref-type="bibr" rid="YEMCS000455C2">2003</xref>; <xref ref-type="bibr" rid="YEMCS000455C5">Desir et al. 2008</xref>). During prenatal development, haploinsufficiency of POGZ would be predicted to lead to depletion of neurogenic progeny, limiting the total number of neurons and resulting in microcephaly. Two of the patients had documented congenital microcephaly to support this mechanism.</p><p>All mutations in our series are predicted to act as loss-of-function alleles and result in haploinsufficiency, either through introducing premature stop codons or abnormal splicing leading to nonsense-mediated mRNA decay. De novo loss of function mutations in <italic>POGZ</italic> have been identified in individuals with autism spectrum disorder, intellectual disability, and schizophrenia (<xref ref-type="bibr" rid="YEMCS000455C12">Iossifov et al. 2012</xref>; <xref ref-type="bibr" rid="YEMCS000455C16">Neale et al. 2012</xref>; <xref ref-type="bibr" rid="YEMCS000455C8">Fromer et al. 2014</xref>; <xref ref-type="bibr" rid="YEMCS000455C9">Gilissen et al. 2014</xref>; <xref ref-type="bibr" rid="YEMCS000455C6">Deciphering Developmental Disorders Study 2015</xref>). Similar to other genes that produce neurodevelopmental disorders, there is a range of related neurobehavioral phenotypes associated with POGZ that includes intellectual disability, autism spectrum disorder, and schizophrenia. The role of POGZ in mitosis suggests a possible role in regulating neuronal proliferation and could explain why patients with <italic>POGZ</italic> mutations are microcephalic and dysmorphic, including anomalies with craniofacial and limb development.</p></sec><sec id="s4" sec-type="methods"><title>METHODS</title><p>Genomic DNA was extracted from whole blood from the affected children and their parents. Exome sequencing was performed on exon targets isolated by capture using the Agilent SureSelect Human All Exon V4 (50-Mb) kit or the Clinical Research Exome (Agilent Technologies). One microgram of DNA from blood specimen was sheared into 350–400-bp fragments, which were then repaired, ligated to adaptors, and purified for subsequent PCR amplification. Amplified products were then captured by biotinylated RNA library baits in solution following the manufacturer's instructions. Bound DNA was isolated with streptavidin-coated beads and reamplified. The final isolated products were sequenced using the Illumina HiSeq 2000 or 2500 sequencing system with 100-bp paired-end reads (Illumina). DNA sequence was mapped to the published human genome build UCSC hg19/GRCh37 reference sequence using BWA with the latest internally validated version at the time of sequencing, progressing from BWA v0.5.8 through BWA-MEM v0.7.8 (<xref ref-type="bibr" rid="YEMCS000455C14">Li and Durbin 2009</xref>; <xref ref-type="bibr" rid="YEMCS000455C13">Li 2012</xref>). Targeted coding exons and splice junctions of known protein-coding RefSeq genes were assessed for average depth of coverage with a minimum depth of 10× required for inclusion in downstream analysis. Local realignment around insertion–deletion sites was performed using the Genome Analysis Toolkit v1.6 (<xref ref-type="bibr" rid="YEMCS000455C4">DePristo et al. 2011</xref>). Variant calls were generated simultaneously on all sequenced family members using SAMtools v0.1.18 (<xref ref-type="bibr" rid="YEMCS000455C15">Li et al. 2009</xref>). All coding exons and surrounding intron/exon boundaries were analyzed. Automated filtering removed common sequence changes (defined as &gt;10% frequency present in 1000 Genomes database). The targeted coding exons and splice junctions of the known protein-coding RefSeq genes were assessed for the average depth of coverage and data quality threshold values. Copy number variants were also called directly from the WES data (<xref ref-type="bibr" rid="YEMCS000455C19">Retterer et al. 2014</xref>). Whole-exome sequence data for all sequenced family members was analyzed using GeneDx's XomeAnalyzer (a variant annotation, filtering, and viewing interface for WES data), which includes nucleotide and amino acid annotations, population frequencies (NHLBI Exome Variant Server and 1000 Genomes databases), in silico prediction tools, amino acid conservation scores, and mutation references. Variants were filtered based on inheritance patterns, gene lists of interest, phenotype, and population frequencies, as appropriate. Resources including the Human Gene Mutation Database (HGMD), 1000 Genomes database, NHLBI Exome Variant Server, OMIM, PubMed, ClinVar, and Exome Aggregation Consortium (ExAC; URL: <uri xlink:href="http://exac.broadinstitute.org">http://exac.broadinstitute.org</uri>) were used to evaluate genes and detected sequence changes of interest. The general assertion criteria for variant classification are publicly available on the GeneDx ClinVar submission page (<uri xlink:href="http://www.ncbi.nlm.nih.gov/clinvar/submitters/26957/">http://www.ncbi.nlm.nih.gov/clinvar/submitters/26957/</uri>). Additional searches were performed using specific gene lists related to ID. Identified sequence changes of interest were confirmed in all members of the trio by conventional di-deoxy DNA sequence analysis using an ABI 3730 (Life Technologies) and standard protocols with a new DNA preparation.</p></sec><sec id="s5"><title>ADDITIONAL INFORMATION</title><sec id="s5a"><title>Ethics Statement</title><p>The study was approved by the Institutional Review Board of Columbia University and written consent was obtained for collecting blood samples and sequencing from all study participants.</p></sec><sec id="s5b"><title>Database Deposition and Access</title><p>Whole-exome sequencing data are not publicly available because patient consent could not be obtained. These <italic>POGZ</italic> variants have been deposited in ClinVar (<uri xlink:href="http://www.ncbi.nlm.nih.gov/clinvar/">http://www.ncbi.nlm.nih.gov/clinvar/</uri>) under accession numbers SCV000240171 and SCV000240173–SCV000240178.</p></sec><sec id="s5c"><title>Acknowledgments</title><p>We thank the families for their generous contribution.</p></sec><sec id="s5d"><title>Author Contributions</title><p>Y.Y. analyzed the data, drafted and critically reviewed the manuscript. M.T.C. analyzed the data and critically reviewed the manuscript. K.R. generated and analyzed the data and critically reviewed the manuscript. N.A. analyzed the data and critically reviewed the manuscript. T.B.-O. provided the clinical data and critically reviewed the manuscript. M.A.-M. provided the clinical data and critically reviewed the manuscript. I.C. provided the clinical data and critically reviewed the manuscript. P.G.W. provided the clinical data and critically reviewed the manuscript. C.C. provided the clinical data and critically reviewed the manuscript. D.Z. provided the clinical data and critically reviewed the manuscript. V.W. provided the clinical data and critically reviewed the manuscript. H.J.V. provided the clinical data and critically reviewed the manuscript. R.M. provided the clinical data and critically reviewed the manuscript. V.K. provided the clinical data and critically reviewed the manuscript. F.M. analyzed the data and critically reviewed the manuscript. W.K.C. conceived of the study, analyzed the data, drafted and critically reviewed the manuscript. P.V. conceived of the study, analyzed the data, drafted and critically reviewed the manuscript.</p></sec><sec id="s5e"><title>Competing Interest Statement</title><p>Y.Y., M.T.C., K.R., N.A., P.V., and F.M. are employees of GeneDx. W.K.C. is a consultant to BioReference Laboratories.</p></sec></sec>
<sec sec-type="supplementary-material">
<title>Supplementary Material</title>
<supplementary-material content-type="local-data" id="PMC_1">
<caption>
<title>Supplemental Material</title>
</caption>
<media mime-subtype="html" mimetype="text" xlink:href="supp_1_1_a000455__index.html"></media>
<media mime-subtype="msword" mimetype="application" xlink:href="supp_1.1.a000455_Supplemental_Table_S1.docx" xlink:role="associated-file"></media>
</supplementary-material>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="supplementary-material">
<p>[Supplemental material is available for this article.]</p>
</fn>
</fn-group>
<ref-list>
<title>REFERENCES</title>
<ref id="YEMCS000455C1">
<mixed-citation publication-type="journal"><name><surname>Bond</surname><given-names>J</given-names></name>, <name><surname>Roberts</surname><given-names>E</given-names></name>, <name><surname>Mochida</surname><given-names>GH</given-names></name>, <name><surname>Hampshire</surname><given-names>DJ</given-names></name>, <name><surname>Scott</surname><given-names>S</given-names></name>, <name><surname>Askham</surname><given-names>JM</given-names></name>, <name><surname>Springell</surname><given-names>K</given-names></name>, <name><surname>Mahadevan</surname><given-names>M</given-names></name>, <name><surname>Crow</surname><given-names>YJ</given-names></name>, <name><surname>Markham</surname><given-names>AF</given-names></name>, <etal></etal>
<year>2002</year>
<article-title>ASPM is a major determinant of cerebral cortical size</article-title>. <source/>Nat Genet
<volume>32</volume>: <fpage>316</fpage>–<lpage>320</lpage>.<pub-id pub-id-type="pmid">12355089</pub-id></mixed-citation>
</ref>
<ref id="YEMCS000455C2">
<mixed-citation publication-type="journal"><name><surname>Bond</surname><given-names>J</given-names></name>, <name><surname>Scott</surname><given-names>S</given-names></name>, <name><surname>Hampshire</surname><given-names>DJ</given-names></name>, <name><surname>Springell</surname><given-names>K</given-names></name>, <name><surname>Corry</surname><given-names>P</given-names></name>, <name><surname>Abramowicz</surname><given-names>MJ</given-names></name>, <name><surname>Mochida</surname><given-names>GH</given-names></name>, <name><surname>Hennekam</surname><given-names>RC</given-names></name>, <name><surname>Maher</surname><given-names>ER</given-names></name>, <name><surname>Fryns</surname><given-names>JP</given-names></name>, <etal></etal>
<year>2003</year>
<article-title>Protein-truncating mutations in ASPM cause variable reduction in brain size</article-title>. <source/>Am J Hum Genet
<volume>73</volume>: <fpage>1170</fpage>–<lpage>1177</lpage>.<pub-id pub-id-type="pmid">14574646</pub-id></mixed-citation>
</ref>
<ref id="YEMCS000455C3">
<mixed-citation publication-type="journal"><name><surname>Carmena</surname><given-names>M</given-names></name>, <name><surname>Wheelock</surname><given-names>M</given-names></name>, <name><surname>Funabiki</surname><given-names>H</given-names></name>, <name><surname>Earnshaw</surname><given-names>WC</given-names></name>. <year>2012</year>
<article-title>The chromosomal passenger complex (CPC): from easy rider to the godfather of mitosis</article-title>. <source/>Nat Rev Mol Cell Biol
<volume>13</volume>: <fpage>789</fpage>–<lpage>803</lpage>.<pub-id pub-id-type="pmid">23175282</pub-id></mixed-citation>
</ref>
<ref id="YEMCS000455C4">
<mixed-citation publication-type="journal"><name><surname>DePristo</surname><given-names>MA</given-names></name>, <name><surname>Banks</surname><given-names>E</given-names></name>, <name><surname>Poplin</surname><given-names>R</given-names></name>, <name><surname>Garimella</surname><given-names>KV</given-names></name>, <name><surname>Maguire</surname><given-names>JR</given-names></name>, <name><surname>Hartl</surname><given-names>C</given-names></name>, <name><surname>Philippakis</surname><given-names>AA</given-names></name>, <name><surname>del Angel</surname><given-names>G</given-names></name>, <name><surname>Rivas</surname><given-names>MA</given-names></name>, <name><surname>Hanna</surname><given-names>M</given-names></name>, <etal></etal>
<year>2011</year>
<article-title>A framework for variation discovery and genotyping using next-generation DNA sequencing data</article-title>. <source/>Nat Genet
<volume>43</volume>: <fpage>491</fpage>–<lpage>498</lpage>.<pub-id pub-id-type="pmid">21478889</pub-id></mixed-citation>
</ref>
<ref id="YEMCS000455C5">
<mixed-citation publication-type="journal"><name><surname>Desir</surname><given-names>J</given-names></name>, <name><surname>Cassart</surname><given-names>M</given-names></name>, <name><surname>David</surname><given-names>P</given-names></name>, <name><surname>Van Bogaert</surname><given-names>P</given-names></name>, <name><surname>Abramowicz</surname><given-names>M</given-names></name>. <year>2008</year>
<article-title>Primary microcephaly with ASPM mutation shows simplified cortical gyration with antero-posterior gradient pre- and post-natally</article-title>. <source/>Am J Med Genet A
<volume>146A</volume>: <fpage>1439</fpage>–<lpage>1443</lpage>.<pub-id pub-id-type="pmid">18452193</pub-id></mixed-citation>
</ref>
<ref id="YEMCS000455C6">
<mixed-citation publication-type="journal"><collab>Deciphering Developmental Disorders Study</collab>. <year>2015</year>
<article-title>Large-scale discovery of novel genetic causes of developmental disorders</article-title>. <source/>Nature
<volume>519</volume>: <fpage>223</fpage>–<lpage>228</lpage>.<pub-id pub-id-type="pmid">25533962</pub-id></mixed-citation>
</ref>
<ref id="YEMCS000455C7">
<mixed-citation publication-type="journal"><name><surname>Fischle</surname><given-names>W</given-names></name>, <name><surname>Tseng</surname><given-names>BS</given-names></name>, <name><surname>Dormann</surname><given-names>HL</given-names></name>, <name><surname>Ueberheide</surname><given-names>BM</given-names></name>, <name><surname>Garcia</surname><given-names>BA</given-names></name>, <name><surname>Shabanowitz</surname><given-names>J</given-names></name>, <name><surname>Hunt</surname><given-names>DF</given-names></name>, <name><surname>Funabiki</surname><given-names>H</given-names></name>, <name><surname>Allis</surname><given-names>CD</given-names></name>. <year>2005</year>
<article-title>Regulation of HP1-chromatin binding by histone H3 methylation and phosphorylation</article-title>. <source/>Nature
<volume>438</volume>: <fpage>1116</fpage>–<lpage>1122</lpage>.<pub-id pub-id-type="pmid">16222246</pub-id></mixed-citation>
</ref>
<ref id="YEMCS000455C8">
<mixed-citation publication-type="journal"><name><surname>Fromer</surname><given-names>M</given-names></name>, <name><surname>Kavanagh</surname><given-names>DH</given-names></name>, <name><surname>Williams</surname><given-names>HJ</given-names></name>, <name><surname>Dwyer</surname><given-names>S</given-names></name>, <name><surname>Gormley</surname><given-names>P</given-names></name>, <name><surname>Georgieva</surname><given-names>L</given-names></name>, <name><surname>Rees</surname><given-names>E</given-names></name>, <name><surname>Palta</surname><given-names>P</given-names></name>, <name><surname>Ruderfer</surname><given-names>DM</given-names></name>, <name><surname>Carrera</surname><given-names>N</given-names></name>, <etal></etal>
<year>2014</year>
<article-title>De novo mutations in schizophrenia implicate synaptic networks</article-title>. <source/>Nature
<volume>506</volume>: <fpage>179</fpage>–<lpage>184</lpage>.<pub-id pub-id-type="pmid">24463507</pub-id></mixed-citation>
</ref>
<ref id="YEMCS000455C9">
<mixed-citation publication-type="journal"><name><surname>Gilissen</surname><given-names>C</given-names></name>, <name><surname>Hehir-Kwa</surname><given-names>JY</given-names></name>, <name><surname>Thung</surname><given-names>DT</given-names></name>, <name><surname>van de Vorst</surname><given-names>M</given-names></name>, <name><surname>van Bon</surname><given-names>BW</given-names></name>, <name><surname>Willemsen</surname><given-names>MH</given-names></name>, <name><surname>Kwint</surname><given-names>M</given-names></name>, <name><surname>Janssen</surname><given-names>IM</given-names></name>, <name><surname>Hoischen</surname><given-names>A</given-names></name>, <name><surname>Schenck</surname><given-names>A</given-names></name>, <etal></etal>
<year>2014</year>
<article-title>Genome sequencing identifies major causes of severe intellectual disability</article-title>. <source/>Nature
<volume>511</volume>: <fpage>344</fpage>–<lpage>347</lpage>.<pub-id pub-id-type="pmid">24896178</pub-id></mixed-citation>
</ref>
<ref id="YEMCS000455C10">
<mixed-citation publication-type="journal"><name><surname>Hanson</surname><given-names>KK</given-names></name>, <name><surname>Kelley</surname><given-names>AC</given-names></name>, <name><surname>Bienz</surname><given-names>M</given-names></name>. <year>2005</year>
<article-title>Loss of <italic>Drosophila</italic> borealin causes polyploidy, delayed apoptosis and abnormal tissue development</article-title>. <source/>Development
<volume>132</volume>: <fpage>4777</fpage>–<lpage>4787</lpage>.<pub-id pub-id-type="pmid">16224046</pub-id></mixed-citation>
</ref>
<ref id="YEMCS000455C11">
<mixed-citation publication-type="journal"><name><surname>Hirota</surname><given-names>T</given-names></name>, <name><surname>Lipp</surname><given-names>JJ</given-names></name>, <name><surname>Toh</surname><given-names>BH</given-names></name>, <name><surname>Peters</surname><given-names>JM</given-names></name>. <year>2005</year>
<article-title>Histone H3 serine 10 phosphorylation by Aurora B causes HP1 dissociation from heterochromatin</article-title>. <source/>Nature
<volume>438</volume>: <fpage>1176</fpage>–<lpage>1180</lpage>.<pub-id pub-id-type="pmid">16222244</pub-id></mixed-citation>
</ref>
<ref id="YEMCS000455C12">
<mixed-citation publication-type="journal"><name><surname>Iossifov</surname><given-names>I</given-names></name>, <name><surname>Ronemus</surname><given-names>M</given-names></name>, <name><surname>Levy</surname><given-names>D</given-names></name>, <name><surname>Wang</surname><given-names>Z</given-names></name>, <name><surname>Hakker</surname><given-names>I</given-names></name>, <name><surname>Rosenbaum</surname><given-names>J</given-names></name>, <name><surname>Yamrom</surname><given-names>B</given-names></name>, <name><surname>Lee</surname><given-names>YH</given-names></name>, <name><surname>Narzisi</surname><given-names>G</given-names></name>, <name><surname>Leotta</surname><given-names>A</given-names></name>, <etal></etal>
<year>2012</year>
<article-title>De novo gene disruptions in children on the autistic spectrum</article-title>. <source/>Neuron
<volume>74</volume>: <fpage>285</fpage>–<lpage>299</lpage>.<pub-id pub-id-type="pmid">22542183</pub-id></mixed-citation>
</ref>
<ref id="YEMCS000455C13">
<mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>H</given-names></name>. <year>2012</year>
<article-title>Exploring single-sample SNP and INDEL calling with whole-genome de novo assembly</article-title>. <source/>Bioinformatics
<volume>28</volume>: <fpage>1838</fpage>–<lpage>1844</lpage>.<pub-id pub-id-type="pmid">22569178</pub-id></mixed-citation>
</ref>
<ref id="YEMCS000455C14">
<mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>H</given-names></name>, <name><surname>Durbin</surname><given-names>R</given-names></name>. <year>2009</year>
<article-title>Fast and accurate short read alignment with Burrows–Wheeler transform</article-title>. <source/>Bioinformatics
<volume>25</volume>: <fpage>1754</fpage>–<lpage>1760</lpage>.<pub-id pub-id-type="pmid">19451168</pub-id></mixed-citation>
</ref>
<ref id="YEMCS000455C15">
<mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>H</given-names></name>, <name><surname>Handsaker</surname><given-names>B</given-names></name>, <name><surname>Wysoker</surname><given-names>A</given-names></name>, <name><surname>Fennell</surname><given-names>T</given-names></name>, <name><surname>Ruan</surname><given-names>J</given-names></name>, <name><surname>Homer</surname><given-names>N</given-names></name>, <name><surname>Marth</surname><given-names>G</given-names></name>, <name><surname>Abecasis</surname><given-names>G</given-names></name>, <name><surname>Durbin</surname><given-names>R</given-names></name>; <collab>1000 Genome Project Data Processing Subgroup</collab>. <year>2009</year>
<article-title>The Sequence Alignment/Map format and SAMtools</article-title>. <source/>Bioinformatics
<volume>25</volume>: <fpage>2078</fpage>–<lpage>2079</lpage>.<pub-id pub-id-type="pmid">19505943</pub-id></mixed-citation>
</ref>
<ref id="YEMCS000455C16">
<mixed-citation publication-type="journal"><name><surname>Neale</surname><given-names>BM</given-names></name>, <name><surname>Kou</surname><given-names>Y</given-names></name>, <name><surname>Liu</surname><given-names>L</given-names></name>, <name><surname>Ma'ayan</surname><given-names>A</given-names></name>, <name><surname>Samocha</surname><given-names>KE</given-names></name>, <name><surname>Sabo</surname><given-names>A</given-names></name>, <name><surname>Lin</surname><given-names>CF</given-names></name>, <name><surname>Stevens</surname><given-names>C</given-names></name>, <name><surname>Wang</surname><given-names>LS</given-names></name>, <name><surname>Makarov</surname><given-names>V</given-names></name>, <etal></etal>
<year>2012</year>
<article-title>Patterns and rates of exonic de novo mutations in autism spectrum disorders</article-title>. <source/>Nature
<volume>485</volume>: <fpage>242</fpage>–<lpage>245</lpage>.<pub-id pub-id-type="pmid">22495311</pub-id></mixed-citation>
</ref>
<ref id="YEMCS000455C17">
<mixed-citation publication-type="journal"><name><surname>Nozawa</surname><given-names>RS</given-names></name>, <name><surname>Nagao</surname><given-names>K</given-names></name>, <name><surname>Masuda</surname><given-names>HT</given-names></name>, <name><surname>Iwasaki</surname><given-names>O</given-names></name>, <name><surname>Hirota</surname><given-names>T</given-names></name>, <name><surname>Nozaki</surname><given-names>N</given-names></name>, <name><surname>Kimura</surname><given-names>H</given-names></name>, <name><surname>Obuse</surname><given-names>C</given-names></name>. <year>2010</year>
<article-title>Human POGZ modulates dissociation of HP1α from mitotic chromosome arms</article-title>. <source/>Nat Cell Biol
<volume>12</volume>: <fpage>719</fpage>–<lpage>727</lpage>.<pub-id pub-id-type="pmid">20562864</pub-id></mixed-citation>
</ref>
<ref id="YEMCS000455C18">
<mixed-citation publication-type="journal"><name><surname>Prasanth</surname><given-names>SG</given-names></name>, <name><surname>Shen</surname><given-names>Z</given-names></name>, <name><surname>Prasanth</surname><given-names>KV</given-names></name>, <name><surname>Stillman</surname><given-names>B</given-names></name>. <year>2010</year>
<article-title>Human origin recognition complex is essential for HP1 binding to chromatin and heterochromatin organization</article-title>. <source/>Proc Natl Acad Sci
<volume>107</volume>: <fpage>15093</fpage>–<lpage>15098</lpage>.<pub-id pub-id-type="pmid">20689044</pub-id></mixed-citation>
</ref>
<ref id="YEMCS000455C19">
<mixed-citation publication-type="journal"><name><surname>Retterer</surname><given-names>K</given-names></name>, <name><surname>Scuffins</surname><given-names>J</given-names></name>, <name><surname>Schmidt</surname><given-names>D</given-names></name>, <name><surname>Lewis</surname><given-names>R</given-names></name>, <name><surname>Pineda-Alvarez</surname><given-names>D</given-names></name>, <name><surname>Stafford</surname><given-names>A</given-names></name>, <name><surname>Schmidt</surname><given-names>L</given-names></name>, <name><surname>Warren</surname><given-names>S</given-names></name>, <name><surname>Gibellini</surname><given-names>F</given-names></name>, <name><surname>Kondakova</surname><given-names>A</given-names></name>, <etal></etal>
<year>2014</year>
<article-title>Assessing copy number from exome sequencing and exome array CGH based on CNV spectrum in a large clinical cohort</article-title>. <source/>Genet Med. <pub-id pub-id-type="doi">10.1038/gim.2014.160</pub-id>.</mixed-citation>
</ref>
<ref id="YEMCS000455C20">
<mixed-citation publication-type="journal"><name><surname>Thornton</surname><given-names>GK</given-names></name>, <name><surname>Woods</surname><given-names>CG</given-names></name>. <year>2009</year>
<article-title>Primary microcephaly: do all roads lead to Rome?</article-title>
<source/>Trends Genet
<volume>25</volume>: <fpage>501</fpage>–<lpage>510</lpage>.<pub-id pub-id-type="pmid">19850369</pub-id></mixed-citation>
</ref>
<ref id="YEMCS000455C21">
<mixed-citation publication-type="journal"><name><surname>Veltman</surname><given-names>JA</given-names></name>, <name><surname>Brunner</surname><given-names>HG</given-names></name>. <year>2012</year>
<article-title>De novo mutations in human genetic disease</article-title>. <source/>Nat Rev Genet
<volume>13</volume>: <fpage>565</fpage>–<lpage>575</lpage>.<pub-id pub-id-type="pmid">22805709</pub-id></mixed-citation>
</ref>
<ref id="YEMCS000455C22">
<mixed-citation publication-type="journal"><name><surname>Yamagishi</surname><given-names>Y</given-names></name>, <name><surname>Sakuno</surname><given-names>T</given-names></name>, <name><surname>Shimura</surname><given-names>M</given-names></name>, <name><surname>Watanabe</surname><given-names>Y</given-names></name>. <year>2008</year>
<article-title>Heterochromatin links to centromeric protection by recruiting shugoshin</article-title>. <source/>Nature
<volume>455</volume>: <fpage>251</fpage>–<lpage>255</lpage>.<pub-id pub-id-type="pmid">18716626</pub-id></mixed-citation>
</ref>
<ref id="YEMCS000455C23">
<mixed-citation publication-type="journal"><name><surname>Yang</surname><given-names>Y</given-names></name>, <name><surname>Muzny</surname><given-names>DM</given-names></name>, <name><surname>Reid</surname><given-names>JG</given-names></name>, <name><surname>Bainbridge</surname><given-names>MN</given-names></name>, <name><surname>Willis</surname><given-names>A</given-names></name>, <name><surname>Ward</surname><given-names>PA</given-names></name>, <name><surname>Braxton</surname><given-names>A</given-names></name>, <name><surname>Beuten</surname><given-names>J</given-names></name>, <name><surname>Xia</surname><given-names>F</given-names></name>, <name><surname>Niu</surname><given-names>Z</given-names></name>, <etal></etal>
<year>2013</year>
<article-title>Clinical whole-exome sequencing for the diagnosis of mendelian disorders</article-title>. <source/>N Engl J Med
<volume>369</volume>: <fpage>1502</fpage>–<lpage>1511</lpage>.<pub-id pub-id-type="pmid">24088041</pub-id></mixed-citation>
</ref>
<ref id="YEMCS000455C24">
<mixed-citation publication-type="journal"><name><surname>Yang</surname><given-names>Y</given-names></name>, <name><surname>Muzny</surname><given-names>DM</given-names></name>, <name><surname>Xia</surname><given-names>F</given-names></name>, <name><surname>Niu</surname><given-names>Z</given-names></name>, <name><surname>Person</surname><given-names>R</given-names></name>, <name><surname>Ding</surname><given-names>Y</given-names></name>, <name><surname>Ward</surname><given-names>P</given-names></name>, <name><surname>Braxton</surname><given-names>A</given-names></name>, <name><surname>Wang</surname><given-names>M</given-names></name>, <name><surname>Buhay</surname><given-names>C</given-names></name>, <etal></etal>
<year>2014</year>
<article-title>Molecular findings among patients referred for clinical whole-exome sequencing</article-title>. <source/>JAMA
<volume>312</volume>: <fpage>1870</fpage>–<lpage>1879</lpage>.<pub-id pub-id-type="pmid">25326635</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>